Cite
HARVARD Citation
Gebrehiwet, P. et al. (2023). Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. Journal of medical economics. pp. 488-493. [Online].